The Netherlands: Europe's connected Life Sciences & Health Metropolis. Life Sciences businesses in the Netherlands profit from countless opportunities for growth and collaboration. The highly collaborative Dutch Life Sciences & Health community includes 3,100 R&D life sciences companies, 420 biopharmaceutical companies, 65,000 employees in pharmaceuticals and a 4.7-billion-euro MedTech market. Not to mention, 26 campuses, 8 university medical centres (UMCs) and 13 universities engaged inLife Sciences research. All this potential is located within a 2.5-hour drive radius. Reasons for investments in the Netherlands: - The gateway to Europe, and the home to the EMA - The world's most concentrated Life Sciences & Health cluster - Outstanding research & education and well-trained professionals - Great quality of life: life simply is good in the Netherlands - Plenty of opportunities for public-private partnerships